Are the Conventional Risk Factors Still Valid for Acute Myeloid Leukemia Patients?

被引：2

作者：

Yildiz, Abdulkerim ^{[1
]}

Maral, Senem ^{[1
]}

Albayrak, Murat ^{[1
]}

Pala, Cigdem ^{[1
]}

Comert, Pinar ^{[1
]}

Ozturk, Hacer Berna Afacan ^{[1
]}

Sahin, Osman ^{[1
]}

机构：

[1] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Hematol, Ankara, Turkey

来源：

KONURALP TIP DERGISI | 2020年 / 12卷 / 01期

关键词：

Leukemia; Survival; Age; Leukocyte; PROGNOSTIC-FACTORS; HYPERLEUKOCYTOSIS; ADULTS; RECOMMENDATIONS; CHEMOTHERAPY; MANAGEMENT; DIAGNOSIS; TREAT; AGE;

D O I：

10.18521/ktd.549666

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: The aim of this study was to investigate the survival data of patients with acute myeloid leukemia (AML) and to determine the risk factors that can be easily evaluated. Methods: A retrospective analysis was made of the AML patients admitted to our center between 2009 and 2018. Demographic and disease data were analyzed and response rates, overall survival (OS) and progression-free survival (PFS) rates were calculated. Factors affecting survival were determined using Cox-regression analysis. Results: A total of 119 patients were included in the study during the 9-year study period. Of these, 21 patients had secondary AML and 11 had acute promyelocytic leukemia (AML-M3). The mean follow-up period was 12.43 +/- 15.63 months. OS of all patients was 9.20 months and PFS was 7.23 months. Age and leukocyte count at the time of diagnosis were significantly found to have adverse effect on both OS and PFS (p<0.05). Conclusions: In addition to genetic and molecular features, which are expensive and difficult to obtain, the age and leukocyte count of AML patients remain important as conventional prognostic factors.

引用

页码：5 / 11

页数：7

共 23 条

[1] The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations [J].

Appelbaum, Frederick R. ;

Kopecky, Kenneth J. ;

Tallman, Martin S. ;

Slovak, Marilyn L. ;

Gundacker, Holly M. ;

Kim, Haesook T. ;

Dewald, Gordon W. ;

Kantarjian, Hagop M. ;

Pierce, Sherry R. ;

Estey, Elihu H. .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) :165-173

[2]

Delaunay Jacques, 2014, Leuk Res Rep, V3, P17, DOI 10.1016/j.lrr.2013.12.001

[3] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[4] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].

Doehner, Hartmut ;

Estey, Elihu H. ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Burnett, Alan K. ;

Dombret, Herve ;

Fenaux, Pierre ;

Grimwade, David ;

Larson, Richard A. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel A. ;

Sierra, Jorge ;

Tallman, Martin S. ;

Loewenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2010, 115 (03) :453-474

[5] Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors [J].

Duployez, Nicolas ;

Willekens, Christophe ;

Marceau-Renaut, Alice ;

Boudry-Labis, Elise ;

Preudhomme, Claude .

EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (01) :43-56

[6] Acute myeloid leukaemia in adults [J].

Ferrara, Felicetto ;

Schiffer, Charles A. .

LANCET, 2013, 381 (9865) :484-495

[7] Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience [J].

Gbadamosi, Bolanle ;

Ezekwudo, Daniel ;

Bastola, Sanjog ;

Jaiyesimi, Ishmael .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (07) :E287-E294

[8] Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia [J].

Greenwood, M. J. ;

Seftel, M. D. ;

Richardson, C. ;

Barbaric, D. ;

Barnett, M. J. ;

Bruyere, H. ;

Forrest, D. L. ;

Horsman, D. E. ;

Smith, C. ;

Song, K. ;

Sutherland, H. J. ;

Toze, C. L. ;

Nevill, T. J. ;

Nantel, S. H. ;

Hogge, D. E. .

LEUKEMIA & LYMPHOMA, 2006, 47 (07) :1245-1252

[9] The changing paradigm of prognostic factors in acute myeloid leukaemia [J].

Grimwade, David .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (04) :419-425

[10] Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry [J].

Juliusson, Gunnar ;

Antunovic, Petar ;

Derolf, Asa ;

Lehmann, Soren ;

Mollgard, Lars ;

Stockelberg, Dick ;

Tidefelt, Ulf ;

Wahlin, Anders ;

Hoglund, Martin .

BLOOD, 2009, 113 (18) :4179-4187

← 1 2 3 →